60 Degrees Pharmaceuticals
SXTP
9 hedge funds and large institutions have $90.1K invested in 60 Degrees Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
29% more funds holding
Funds holding: 7 → 9 (+2)
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
29% less capital invested
Capital invested by funds: $127K → $90.1K (-$36.5K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$10K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.14K |
| 3 |
HF
HRT Financial
New York
|
+$7.62K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$2.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$63 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBT
Central Bank & Trust
Lexington,
Kentucky
|
-$26.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$26.3K |
| 3 |
VF
Virtu Financial
New York
|
-$3.81K |
| 4 |
Renaissance Technologies
New York
|
-$3K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$1.84K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CBT
1
Central Bank & Trust
Lexington,
Kentucky
| $41.8K | -$26.7K | -421 | -38% |
|
|
VF
2
Virtu Financial
New York
| $11K | -$3.81K | -60 | -24% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $9.61K | +$10K | +158 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $8.72K | +$9.14K | +144 | New |
|
|
HF
5
HRT Financial
New York
| $7K | +$7.62K | +120 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $4.35K | -$1.84K | -29 | -29% |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3.36K | -$63 | -1 | -2% |
|
|
RJA
8
Raymond James & Associates
St Petersburg,
Florida
| $2.53K | +$2.67K | +42 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1.79K | +$63 | +1 | +3% |
|
10
Bank of America
Charlotte,
North Carolina
| $14 | – | – | – |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$26.3K | -419 | Closed |
|
|
12
Renaissance Technologies
New York
| – | -$3K | -52 | Closed |
|
13
Wells Fargo
San Francisco,
California
| – | -$14 | – | – |
|
SXTP Hedge Fund Activity: Q2 2024 in Review
9 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q2 2024, worth a combined $90.1K — down 29% from $127K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SXTP positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $10K. The largest seller was Central Bank & Trust, cutting an estimated $26.7K.
- 9 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q2 2024, up from 7 in Q1 2024.
- Funds reported $90.1K of 60 Degrees Pharmaceuticals stock for Q2 2024, down 29% quarter-over-quarter.
- 4 funds opened new 60 Degrees Pharmaceuticals positions in Q2 2024 and 2 closed out, a net change of +2 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q2 2024 was Geode Capital Management, an estimated $10K added.
- The largest 60 Degrees Pharmaceuticals seller in Q2 2024 was Central Bank & Trust, an estimated $26.7K sold.
Based on aggregated 13F filings for Q2 2024.